• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳曲吲哚对大鼠吗啡诱导的耐受性和身体依赖性的不同作用。

Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats.

作者信息

Hepburn M J, Little P J, Gingras J, Kuhn C M

机构信息

Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

J Pharmacol Exp Ther. 1997 Jun;281(3):1350-6.

PMID:9190871
Abstract

This study investigated the effect of delta opioid receptor blockade by naltrindole on the development of physical dependence and tolerance to the antinociceptive and respiratory depressive effects of morphine in rats. Chronic morphine was delivered either by s.c. injection of increasing amounts of morphine over 5 days or by s.c. implantation of morphine pellets. Animals were cotreated with saline or naltrindole. Antinociception and respiratory depression were assessed after administration of a challenge dose of morphine, and withdrawal signs were determined after naloxone challenge. Naltrindole significantly attenuated the development of antinociceptive tolerance after all three chronic treatment regimens. In addition, rats pretreated with naltrindole displayed significantly fewer withdrawal symptoms and less weight loss after a naloxone challenge. In contrast, naltrindole did not prevent the development of tolerance to morphine-induced respiratory depression. These results imply that tolerance to antinociception and physical dependence involves adaptations at interacting mu and delta receptor populations, whereas tolerance to respiratory depression reflects actions of independent mu and delta receptor populations. These findings suggest that delta antagonists may have potential clinical application for decreasing the rapid development of tolerance to opiate-induced analgesia, while allowing for the development of protective tolerance to respiratory depression.

摘要

本研究调查了纳曲吲哚对δ阿片受体的阻断作用,对大鼠吗啡抗伤害感受和呼吸抑制作用的身体依赖性及耐受性发展的影响。慢性吗啡给药方式为:在5天内皮下注射递增剂量的吗啡,或皮下植入吗啡缓释微丸。动物同时接受生理盐水或纳曲吲哚治疗。给予一剂激发剂量的吗啡后评估抗伤害感受和呼吸抑制情况,给予纳洛酮激发后确定戒断症状。在所有三种慢性治疗方案后,纳曲吲哚均显著减弱了抗伤害感受耐受性的发展。此外,用纳曲吲哚预处理的大鼠在接受纳洛酮激发后,出现的戒断症状显著减少,体重减轻也较少。相比之下,纳曲吲哚并未阻止对吗啡诱导的呼吸抑制耐受性的发展。这些结果表明,对抗伤害感受和身体依赖性的耐受性涉及相互作用的μ和δ受体群体的适应性变化,而对呼吸抑制的耐受性反映了独立的μ和δ受体群体的作用。这些发现表明,δ拮抗剂可能具有潜在的临床应用价值,可减少对阿片类药物诱导镇痛耐受性的快速发展,同时允许对呼吸抑制产生保护性耐受性。

相似文献

1
Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats.纳曲吲哚对大鼠吗啡诱导的耐受性和身体依赖性的不同作用。
J Pharmacol Exp Ther. 1997 Jun;281(3):1350-6.
2
Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.选择性阻断δ阿片受体可预防小鼠吗啡耐受性和依赖性的发展。
J Pharmacol Exp Ther. 1991 Jul 1;258(1):299-303.
3
Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.δ阿片受体亚型2而非δ阿片受体亚型1在慢性炎性疼痛大鼠模型吗啡镇痛耐受性形成中的作用
Eur J Neurosci. 2015 Apr;41(7):901--7. doi: 10.1111/ejn.12829. Epub 2015 Jan 9.
4
Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.δ-阿片受体在介导大鼠吗啡戒断厌恶刺激效应中的作用。
Eur J Pharmacol. 1996 Apr 4;300(1-2):17-24. doi: 10.1016/0014-2999(95)00860-8.
5
Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists.低剂量阿片受体拮抗剂对脊髓吗啡镇痛耐受性的抑制作用。
Eur J Pharmacol. 2007 Apr 10;560(2-3):132-41. doi: 10.1016/j.ejphar.2006.12.013. Epub 2007 Jan 17.
6
In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.SoRI 9409的体内药理学特性,SoRI 9409是一种非肽类阿片μ激动剂/δ拮抗剂,产生有限的抗伤害感受耐受性并减轻吗啡身体依赖性。
J Pharmacol Exp Ther. 2001 May;297(2):597-605.
7
In vivo activation of a mutant mu-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: role of mu-receptor activation and delta-receptor blockade in morphine tolerance.纳曲酮在体内激活突变型μ-阿片受体可产生强效镇痛作用但无耐受性:μ-受体激活和δ-受体阻断在吗啡耐受性中的作用
J Neurosci. 2005 Mar 23;25(12):3229-33. doi: 10.1523/JNEUROSCI.0332-05.2005.
8
Co-activation of μ- and δ-opioid receptors elicits tolerance to morphine-induced ventilatory depression via generation of peroxynitrite.μ 型和 δ 型阿片受体的共同激活通过生成过氧亚硝酸盐引发吗啡诱导的通气抑制耐受。
Respir Physiol Neurobiol. 2013 May 1;186(3):255-64. doi: 10.1016/j.resp.2013.02.028. Epub 2013 Mar 5.
9
Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.纳洛酮、D-苯丙氨酸-半胱氨酸-酪氨酸-D-色氨酸-精氨酸-苏氨酸-青霉胺-苏氨酸-NH2以及蛋白激酶抑制剂H7和H8对小鼠急性吗啡依赖性和抗伤害感受性耐受性的影响。
J Pharmacol Exp Ther. 1996 Apr;277(1):484-90.
10
The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.N-甲基-D-天冬氨酸(NMDA)受体数量在对吗啡超敏性或耐受性及依赖性形成过程中的重要性。
Pharmacol Res. 1999 Apr;39(4):311-9. doi: 10.1006/phrs.1998.0443.

引用本文的文献

1
Tryptophan Substitution in CJ-15,208 ([Phe-D-Pro-Phe-Trp]) Introduces δ-Opioid Receptor Antagonism, Preventing Antinociceptive Tolerance and Stress-Induced Reinstatement of Extinguished Cocaine-Conditioned Place Preference.在CJ-15,208([苯丙氨酸-右旋脯氨酸-苯丙氨酸-色氨酸])中用色氨酸替代引入了δ-阿片受体拮抗作用,可预防抗伤害感受耐受性以及应激诱导的已消退可卡因条件性位置偏爱恢复。
Pharmaceuticals (Basel). 2023 Aug 29;16(9):1218. doi: 10.3390/ph16091218.
2
Differential Effects of a Novel Opioid Ligand UTA1003 on Antinociceptive Tolerance and Motor Behaviour.新型阿片类配体UTA1003对镇痛耐受性和运动行为的不同影响。
Pharmaceuticals (Basel). 2022 Jun 24;15(7):789. doi: 10.3390/ph15070789.
3
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review.
阿片类镇痛与阿片类药物所致不良反应:综述
Pharmaceuticals (Basel). 2021 Oct 27;14(11):1091. doi: 10.3390/ph14111091.
4
SAR Matrices Enable Discovery of Mixed Efficacy μ-Opioid Receptor Agonist Peptidomimetics with Simplified Structures through an Aromatic-Amine Pharmacophore.SAR 矩阵通过芳香胺药效团使具有简化结构的混合效力 μ-阿片受体激动剂肽模拟物的发现成为可能。
ACS Chem Neurosci. 2021 Jan 6;12(1):216-233. doi: 10.1021/acschemneuro.0c00693. Epub 2020 Dec 21.
5
Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles.苯丙氨酸 CJ-15,208 和[d-Trp]CJ-15,208 的立体异构体表现出明显不同的阿片样活性特征。
Molecules. 2020 Sep 2;25(17):3999. doi: 10.3390/molecules25173999.
6
Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.5'-芳基-14-烷氧基吡啶并吗啡烷类的合成及构效关系研究:具有系统镇痛活性和减轻阿片类副作用的μ阿片受体激动剂/δ阿片受体拮抗剂配体的鉴定。
J Med Chem. 2020 Jul 23;63(14):7663-7694. doi: 10.1021/acs.jmedchem.0c00503. Epub 2020 Jun 30.
7
Aromatic-Amine Pendants Produce Highly Potent and Efficacious Mixed Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Peptidomimetics with Enhanced Metabolic Stability.芳胺取代物生成高效能、有效混合μ-阿片受体(MOR)/δ-阿片受体(DOR)肽类似物,具有增强的代谢稳定性。
J Med Chem. 2020 Feb 27;63(4):1671-1683. doi: 10.1021/acs.jmedchem.9b01818. Epub 2020 Feb 10.
8
Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show Kappa and Mu Opioid Receptor Agonism.新型含芳香四氢异喹啉取代基的二甲基酪氨酸-四氢异喹啉肽拟似物具有 κ 和 μ 阿片受体激动活性。
ACS Chem Neurosci. 2019 Aug 21;10(8):3682-3689. doi: 10.1021/acschemneuro.9b00250. Epub 2019 Jul 1.
9
Structural Simplification of a Tetrahydroquinoline-Core Peptidomimetic μ-Opioid Receptor (MOR) Agonist/δ-Opioid Receptor (DOR) Antagonist Produces Improved Metabolic Stability.四氢喹啉核心肽拟似物 μ 型阿片受体(MOR)激动剂/δ 型阿片受体(DOR)拮抗剂的结构简化提高了代谢稳定性。
J Med Chem. 2019 Apr 25;62(8):4142-4157. doi: 10.1021/acs.jmedchem.9b00219. Epub 2019 Apr 12.
10
Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand Design.通过构效关系 (SAR) 矩阵探索双重药效基团:深入了解强效双功能阿片类配体设计。
J Med Chem. 2019 Apr 25;62(8):4193-4203. doi: 10.1021/acs.jmedchem.9b00378. Epub 2019 Apr 9.